Now is the time to implement a simple, on demand print solution for ISBT 128 labeling. Use our HemaTrax®-CT cellular therapy product labeling system to ensure your facility meets these standards.
The new edition (version 7) (see pdf at right) of the FACT-JACIE International Standards for Hematopoietic Cellular Therapy was published March 1, 2018. Please note implementation of ISBT 128 labeling is required for FACT-JACIE accreditation effective May 20, 2018. Don’t be ISBT 128 non-compliant! Implementation of our HemaTrax®-CT system includes a printer, proprietary software, ribbons and labels— all required for ISBT 128 compliance. There are two ways to use HemaTrax-CT. You can run it standalone meaning no other software is required and it can integrate with cellular therapy systems shown below. You will receive access to our easy to use software. By entering your label information on just a few screens, you can simply and quickly print cellular therapy identification labels.